Funded Tech Companies
Eradivir
Eradivir, based in West Lafayette, received equity investments from private investors.
Company Overview
Company Name
Eradivir
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
1281 Win Hentschel Boulevard
West Lafayette, IN 47906
USA
West Lafayette, IN 47906
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Eradivir's founder, Dr. Philip S. Low, has successfully developed multiple FDA-approved targeted small molecules. These therapies all function by attaching various payloads to ligands, which bind with high specificity to diseased cells. Examples of approved molecules include a radiotherapy drug for prostate cancer and an intraoperative imaging agent for lung and ovarian cancers. Several others are currently in clinical trials (e.g., treatments for cancer, malaria, and sickle cell anemia). Eradivir was founded in March 2020 to advance a promising application of this platform in combating multiple disease states, initially focusing on influenza and other respiratory infections.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/26/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Low
Chief Operating Officer
Stewart Low
Chief Scientific Officer
Philip Low
Vice President
Madduri Srinivasarao
VP - R & D
Ananda Kanduluru
VP - R & D
Jeffery Nielsen
Company Investors
- Private Investors (Philip Low)
Browse more funded tech companies:
Era Software | EraGen Biosciences
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs